Comparing TC and Anthracycline * Taxane Chemotherapy

This study evaluates the comparative efficacy and safety of anthracycline-taxane chemotherapy versus TC chemotherapy regimens, focusing on Disease-Free Survival (DFS), Overall Survival (OS), and cardiotoxicity. Utilizing robust study designs, subgroup analyses by ER status, and comprehensive data techniques, findings highlight efficacy differentials, safety profiles, and clinical implications. The discussion underscores therapeutic considerations, tolerance, and study limitations, presenting...